Calcium and Rowasa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Calcium (calcium) and Rowasa (mesalamine). Common drug interactions include cerebellar atrophy among females and cardiogenic shock among males.

The phase IV clinical study analyzes what interactions people have when they take Calcium and Rowasa. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Calcium?

Calcium has active ingredients of calcium. It is often used in osteoporosis. eHealthMe is studying from 184,201 Calcium users. Check the latest studies of Calcium.

What is Rowasa?

Rowasa has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 943 Rowasa users. Check the latest studies of Rowasa.



On Jul, 06, 2026

18 people who take Calcium and Rowasa together, and have interactions are studied.

Calcium and Rowasa drug interactions.

What are the common drug interactions of Calcium and Rowasa, by gender? *:

female:

  1. Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
  2. Neuropathy peripheral (surface nerve damage)
  3. Spasmodic dysphonia (a voice disorder characterized by involuntary movements or spasms of one or more muscles of the larynx)
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Ataxia (loss of full control of bodily movements)
  6. Balance disorder
  7. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  8. Dysarthria (speech disorder)
  9. Gait disturbance
  10. Muscular weakness (muscle weakness)

male:

  1. Cardiogenic shock (inadequate circulation of blood)
  2. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  3. Amylase increased
  4. Angiotensin converting enzyme increased
  5. Asthenia (weakness)
  6. Bence jones proteinuria (immunoglobulin light chain found in the urine)
  7. Blood calcium decreased
  8. Blood creatinine increased
  9. Blood prolactin increased
  10. Blood testosterone decreased

What are the common drug interactions of Calcium and Rowasa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Infusion related reaction
  2. Petit mal epilepsy (absence seizure)
  3. Staring (a prolonged gaze or fixed look)

40-49:

  1. Oral pain

50-59:

  1. Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
  2. Neuropathy peripheral (surface nerve damage)
  3. Spasmodic dysphonia (a voice disorder characterized by involuntary movements or spasms of one or more muscles of the larynx)
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Ataxia (loss of full control of bodily movements)
  6. Balance disorder
  7. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  8. Dysarthria (speech disorder)
  9. Gait disturbance
  10. Muscular weakness (muscle weakness)

60+:

  1. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  2. Pruritus (severe itching of the skin)
  3. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Diarrhoea
  6. Dyspnoea (difficult or laboured respiration)
  7. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  8. Inflammation
  9. Lipase increased
  10. Lymphopenia (an abnormally low level of lymphocytes in the blood)

What are the existing conditions these people have? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 27.78%
  2. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 22.22%
  3. Sinusitis (inflammation of sinus): 4 people, 22.22%
  4. Headache (pain in head): 4 people, 22.22%
  5. Pain: 4 people, 22.22%
  6. Hot Flush (sudden feelings of heat): 4 people, 22.22%
  7. Wheezing (a high-pitched whistling sound made while you breath): 3 people, 16.67%
  8. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 16.67%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
  10. Colitis (inflammation of colon): 3 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Calcium and Rowasa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Calcium and Rowasa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rowasa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Calcium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rowasa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on calcium and mesalamine (the active ingredients of Calcium and Rowasa, respectively), and Calcium and Rowasa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: